Showing results (21-30 of 76) with videos related to
Sort By:
Pageof 8
Journal of Cancer Research and Clinical Oncology|June 20, 2016
The earlier the better? Bevacizumab in the treatment of recurrent MGMT-non-methylated glioblastomaChristina Schaub, Niklas Schäfer, Frederic Mack, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 16, 2016
Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS LymphomaAgnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger, et al.World Neurosurgery|July 26, 2020
Challenging Implications of Chronic Lymphocytic Inflammation with Pontine Perivascular Enhancement Responsive to Steroids Syndrome with an Atypical Presentation: Report of Two CasesLaurèl Rauschenbach, Sied Kebir, Alexander Radbruch, et al.Experimental Cell Research|September 19, 2016
Sarcomeric lesions and remodeling proximal to intercalated disks in overload-induced cardiac hypertrophySied Kebir, Zacharias Orfanos, Julia Schuld, et al.Experimental Hematology & Oncology|December 11, 2012
Intravascular CNS lymphoma: Successful therapy using high-dose methotrexate-based polychemotherapySied Kebir, Klaus Kuchelmeister, Pitt Niehusmann, et al.Plos One|November 21, 2015
Tlr4 Deficiency Protects against Cardiac Pressure Overload Induced HyperinflammationHeidi Ehrentraut, Stefan Felix Ehrentraut, Olaf Boehm, et al.Clinical Neurology and Neurosurgery|November 7, 2020
Demographic, radiographic, molecular and clinical characteristics of primary gliosarcoma and differences to glioblastomaDaniela Pierscianek, Yahya Ahmadipour, Anna Michel, et al.Journal of Translational Medicine|March 22, 2019
Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumorsNiklas Schäfer, Gerrit H Gielen, Laurèl Rauschenbach, et al.Future Oncology (London, England)|October 21, 2021
Electrolyte and renal disorders in patients with newly diagnosed glioblastomaDaniela Pierscianek, Marvin Darkwah Oppong, Yahya Ahmadipour, et al.European Journal of Nuclear Medicine and Molecular Imaging|March 23, 2018
Use of FET PET in glioblastoma patients undergoing neurooncological treatment including tumour-treating fields: initial experienceGarry Ceccon, Lazaros Lazaridis, Gabriele Stoffels, et al.Pageof 8